References
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
OsterriederandHolck(1989)InvitropharmacologicprofileofRo40-5967,anovelCa2+channelblockerwithpotentvasodilatorbutweakinotropicaction.J.Cardiovasc.Pharmacol.13754PMID:2472524
Veniantetal(1991)HemodynamicprofileofRo40-5967inconsciousrats:comparisonwithdiltiazem,verapamil,andamlodipine.J.Cardiovasc.Pharmacol.18S55PMID:1725005
Mehrkeetal(1994)TheCa(++)-channelblockerRo40-5967blocksdifferentlyT-typeandL-typeCa++channels.J.Pharmacol.Exp.Ther.2711483PMID:7996461
Keywords:Mibefradildihydrochloride,supplier,Ca2+,channel,blockers,T-type,Calcium,CaV,Channels,L-Type,P-Type,R-Type,Q-Type,T-Type,N-Type,voltage-gated,voltage-dependent,Ro405967,Ro,40-5967,Voltage-gated,Calcium,Channels,Voltage-gated,Calcium,Channels,TocrisBioscience